Back to Search Start Over

De novo putative loss-of-function variants in TAF4 are associated with a neuro-developmental disorder.

Authors :
Janssen BDE
van den Boogaard MH
Lichtenbelt K
Seaby EG
Stals K
Ellard S
Newbury-Ecob R
Dixit A
Roht L
Pajusalu S
Õunap K
Firth HV
Buckley M
Wilson M
Roscioli T
Tidwell T
Mao R
Ennis S
Holwerda SJ
van Gassen K
van Jaarsveld RH
Source :
Human mutation [Hum Mutat] 2022 Dec; Vol. 43 (12), pp. 1844-1851. Date of Electronic Publication: 2022 Aug 10.
Publication Year :
2022

Abstract

TATA-binding protein associated factor 4 (TAF4) is a subunit of the Transcription Factor IID (TFIID) complex, a central player in transcription initiation. Other members of this multimeric complex have been implicated previously as monogenic disease genes in human developmental disorders. TAF4 has not been described to date as a monogenic disease gene. We here present a cohort of eight individuals, each carrying de novo putative loss-of-function (pLoF) variants in TAF4 and expressing phenotypes consistent with a neuro-developmental disorder (NDD). Common features include intellectual disability, abnormal behavior, and facial dysmorphisms. We propose TAF4 as a novel dominant disease gene for NDD, and coin this novel disorder "TAF4-related NDD" (T4NDD). We place T4NDD in the context of other disorders related to TFIID subunits, revealing shared features of T4NDD with other TAF-opathies.<br /> (© 2022 The Authors. Human Mutation published by Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1098-1004
Volume :
43
Issue :
12
Database :
MEDLINE
Journal :
Human mutation
Publication Type :
Academic Journal
Accession number :
35904126
Full Text :
https://doi.org/10.1002/humu.24444